Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Infectious Diseases (London, England)|March 5, 2025
Comparison of the in vivo efficacy and resistance development potential between cefiderocol and ceftolozane/tazobactam human simulated exposures against Pseudomonas aeruginosa in 72-hour murine thigh infection modelAliaa Fouad, Samantha E Nicolau, Pranita D Tamma, et al.
The Journal of Antimicrobial Chemotherapy|October 23, 2024
Differential frequency of persister cells in clinically derived isolates of Pseudomonas aeruginosa after exposure to cefiderocol and ceftolozane/tazobactamAliaa Fouad, Samantha E Nicolau, Pranita D Tamma, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 15, 2024
Dose optimization of piperacillin/tazobactam, cefepime, and ceftazidime for carbapenem-resistant Pseudomonas aeruginosa isolates in TürkiyeEcem Buyukyanbolu, Christian M Gill, Leyla Genc, et al.
Open Forum Infectious Diseases|May 30, 2024
Deciphering the Efficacy of β-Lactams in the Face of Metallo-β-Lactamase-Derived Resistance in Enterobacterales: Supraphysiologic Zinc in the Broth Is the CulpritKamilia Abdelraouf, Christian M Gill, Matthew Gethers, et al.
Journal of Clinical Microbiology|October 29, 2020
Evaluation of the Xpert Carba-R NxG Assay for Detection of Carbapenemase Genes in a Global Challenge Set of Pseudomonas aeruginosa IsolatesChristian M Gill, Tomefa E Asempa, Isabella A Tickler, et al.
Jac-Antimicrobial Resistance|May 9, 2022
Assessment of sustained efficacy and resistance emergence under human-simulated exposure of cefiderocol against Acinetobacter baumannii using in vitro chemostat and in vivo murine infection modelsChristian M Gill, Kamilia Abdelraouf, Merime Oota, et al.
Diagnostic Microbiology and Infectious Disease|June 29, 2019
T2 Candida versus beta-D-glucan to facilitate antifungal discontinuation in the intensive care unitChristian M Gill, Rachel M Kenney, Laura Hencken, et al.
The Journal of Antimicrobial Chemotherapy|July 2, 2021
Discrepancy in sustained efficacy and resistance emergence under human-simulated exposure of cefiderocol against Stenotrophomonas maltophilia between in vitro chemostat and in vivo murine infection modelsChristian M Gill, Kamilia Abdelraouf, Merime Oota, et al.
Antimicrobial Agents and Chemotherapy|July 26, 2021
Phenotypic/Genotypic Profile of OXA-10-Like-Harboring, Carbapenem-Resistant Pseudomonas aeruginosa: Using Validated Pharmacokinetic/Pharmacodynamic In Vivo Models To Further Evaluate Enzyme Functionality and Clinical ImplicationsChristian M Gill, Adrian Brink, Chun Yat Chu, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2021
Elevated MICs of Susceptible Antipseudomonal Cephalosporins in Non-Carbapenemase-Producing, Carbapenem-Resistant Pseudomonas aeruginosa: Implications for Dose OptimizationChristian M Gill, Elif Aktaş, Wadha Alfouzan, et al.
Pageof 6